Wixela vs Breo
What to choose Wixela or Breo
Wixela is inhaler of type Control while Breo is of Rescue type. Wixela and Breo are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Breo is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Breo is Vilanterol. The available dosages for Breo are 100/25, 200/25.
The average cost for Wixela is approximately $240 while current price for Breo is approximately $145, said Kristian Mitchell, a Lecturer at the Furman University and an Advanced Medical Support Assistant at a clinic that uses Wixela and Breo.
Wixela and Breo Comparison
| Wixela | Breo | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | Viatris | GSK |
| Substance: | Fluticasone + Salmeterol | Vilanterol |
| Dosage: | 250/50 | 100/25, 200/25 |
| Avg Price: | $240 | $145 |